Terms: = Ovarian cancer AND COL1A1, P02452, 1277, ENSG00000108821, OI4 AND Diagnosis
3 results:
1. The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in
Philpott S; Raikou M; Manchanda R; Lockley M; Singh N; Scott M; Evans DG; Adlard J; Ahmed M; Edmondson R; Woodward ER; Lamnisos A; Balega J; Brady AF; Sharma A; Izatt L; Kulkarni A; Tripathi V; Solomons JS; Hayes K; Hanson H; Snape K; Side L; Skates S; McGuire A; Rosenthal AN
J Med Genet; 2023 May; 60(5):440-449. PubMed ID: 36319079
[TBL] [Abstract] [Full Text] [Related]
2. A novel diagnostic nomogram based on serological and ultrasound findings for preoperative prediction of malignancy in patients with ovarian masses.
Guo Y; Jiang T; Ouyang L; Li X; He W; Zhang Z; Shen H; You Z; Yang G; Lai H
Gynecol Oncol; 2021 Mar; 160(3):704-712. PubMed ID: 33357959
[TBL] [Abstract] [Full Text] [Related]
3. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer.
Günel T; Gumusoglu E; Dogan B; Ertem FB; Hosseini MK; Cevik N; Senol T; Topuz S; Aydinli K
Arch Gynecol Obstet; 2018 Dec; 298(6):1173-1180. PubMed ID: 30264202
[TBL] [Abstract] [Full Text] [Related]
